Osborne Clarke - USA’s Post

Landing innovation into the health and social care sector is next to impossible if you can’t explain in year benefits in terms of cutting costs or improving productivity, balanced with contribution to the long term sustainability of the care system through prevention. If you’ve only got one of these stories in your value proposition, innovator, you’re in for a tough year. But you can get help by bringing industry collaboration to the table. Have a Quick Look at this discussion.

The Duke-NUS Centre of Regulatory Excellence (CoRE) is set to commemorate its 10th anniversary on the 14 th – 15 th October 2024, with a landmark event—the CoRE Scientific Conference themed & "Regulating the Future of Health: Converging Products & Services Regulation for Access, Innovation & Sustainability." This event, along with a Celebratory Networking Evening and Graduation Ceremony, marks a significant milestone in CoRE's decade-long journey of achievements and contributions to the field of health regulation. This year's event is a unique platform for professionals, policymakers, and thought leaders across MedTech, Pharma, and Healthcare to collaboratively tackle pressing regulatory challenges. The programme is designed around four exciting themes—Regulating Artificial Intelligence & Digital Health, Regulating Precision Medicine, Regulating for Disease Prevention, and Partnerships for Effective Regulation—with an aim to foster meaningful dialogues, shape future perspectives, and enhance collaboration among key stakeholders in the regulatory ecosystem.

So enlightening to learn how the need for LM is felt in different important departments of administration.

🚀 Challenging conventional wisdom in healthcare innovation! Join us for a thought-provoking roundtable: "The Fallacy of Having Evidence Dictate Your Business Model" Ever wondered if our rigid adherence to traditional evidence-based approaches might actually be holding back healthcare innovation? 🤔 Join industry leaders Adam Kaufman (EVERSANA) and Rick Bartels, (DTxCC (Digital Therapeutics Commercialization Consultants, LLC) for a candid conversation about finding the sweet spot between clinical evidence and entrepreneurial agility in digital health. Key discussion points: ✅ Balancing evidence requirements with market dynamics ✅ Alternative validation methods in digital health ✅ Reimagining regulatory approaches for innovation Apply to attend 🔗 https://lnkd.in/eHz_sCvd Don't miss this opportunity to explore how we can drive healthcare innovation while maintaining quality and safety standards! #DigitalHealth #HealthcareInnovation #HLTH #HealthTech

🌟 Discover how UCB is transforming the healthcare landscape under the visionary leadership of CEO @Jean-Christophe Tellier! In a world where healthcare is evolving rapidly, UCB is at the forefront, breaking silos and fostering co-creation to enhance patient care and innovation. 🔬 From leveraging technology and AI to accelerate access to innovative treatments, to amplifying the patient's voice in clinical trials and regulatory processes, UCB is setting new standards in healthcare. Their commitment is not just about new medicines, but about empowering patients to live their desired lives, rather than one dictated by disease. 💡 Want to learn more about how UCB is leading the charge in creating a unified, value-based healthcare system? Download our latest publication to dive deep into their innovative strategies and future vision for a healthier society. 🔗 https://lnkd.in/eJKbnJCH #OneUnifiedModel #UCB #PwCBelgium

🌟 Perfect conclusion for Day 2 of the MedTech Summit 2024 in Chicago's Safety and Compliance Track! The engaging roundtable discussion on “Analyzing the Validity for RWE Support to Clinical and Post Market Evaluations” led by Nicole Wydeven, PhD, Sr. Manager of Post Market Clinical Strategy, provided valuable insights into the pivotal role of real-world evidence (RWE) in healthcare. This session marked an impactful finale, highlighting the importance of data-driven approaches in clinical and post-market evaluations. Let's continue driving innovation with evidence-based strategies! 🚀 #MedTechSummit #WhySummits #SafetyAndCompliance #RWE #HealthcareInnovation

𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬! 🧬 Kamilla Posselt dives into the evolution of trial design in her article. Discover how embedding digital and decentralized solutions during early trial development ensures a seamless and participant-centric approach. From reducing site visits to leveraging advanced technologies, the future of clinical research is here—and it’s accessible, efficient, and inclusive. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐭𝐨 𝐢𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐞 𝐭𝐡𝐞𝐬𝐞 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐢𝐧𝐭𝐨 𝐲𝐨𝐮𝐫 𝐩𝐫𝐨𝐭𝐨𝐜𝐨𝐥𝐬 𝐭𝐨𝐝𝐚𝐲.  𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞: https://lnkd.in/grH7xBUd #clinicalresearch #decentralizedtrials #digitalhealth #innovation #patientcentricity #dctstrategy #lifesciences #digitaltransformation #futureofhealth #healthcareinnovation #pharmafocusasia

🌟 Discover how UCB is transforming the healthcare landscape under the visionary leadership of CEO @Jean-Christophe Tellier! In a world where healthcare is evolving rapidly, UCB is at the forefront, breaking silos and fostering co-creation to enhance patient care and innovation. 🔬 From leveraging technology and AI to accelerate access to innovative treatments, to amplifying the patient's voice in clinical trials and regulatory processes, UCB is setting new standards in healthcare. Their commitment is not just about new medicines, but about empowering patients to live their desired lives, rather than one dictated by disease. 💡 Want to learn more about how UCB is leading the charge in creating a unified, value-based healthcare system? Download our latest publication to dive deep into their innovative strategies and future vision for a healthier society. 🔗 https://lnkd.in/eF-PDwtt #OneUnifiedModel #UCB #PwCBelgium

🌟 Discover how UCB is transforming the healthcare landscape under the visionary leadership of CEO @Jean-Christophe Tellier! In a world where healthcare is evolving rapidly, UCB is at the forefront, breaking silos and fostering co-creation to enhance patient care and innovation. 🔬 From leveraging technology and AI to accelerate access to innovative treatments, to amplifying the patient's voice in clinical trials and regulatory processes, UCB is setting new standards in healthcare. Their commitment is not just about new medicines, but about empowering patients to live their desired lives, rather than one dictated by disease. 💡 Want to learn more about how UCB is leading the charge in creating a unified, value-based healthcare system? Download our latest publication to dive deep into their innovative strategies and future vision for a healthier society. 🔗 https://lnkd.in/edmNG9B6 #OneUnifiedModel #UCB #PwCBelgium

The Pharma industry is on the verge of radical change, and the choice is ours—will we lead the transformation, or let it happen to us? Here are the key shifts driving this evolution that I got from the amazing Pharmageddon conference in Amsterdam this week: 👥 Customer-Centricity: We must reorganize around the customer, ensuring that HCP and patient needs are at the heart of everything we do. 🏆 One Team, One Goal: Break down internal silos and stop competing for resources. We’re stronger together. 💻 Digital & Data: Leveraging the power of digital health and data will be key to staying ahead of the curve. 🤝 Beyond the Pill: It's time to partner outside of traditional Pharma—innovation demands collaboration across industries. 🩺 From Treatment to Prevention: Shift focus from simply treating illness to helping patients predict and prevent health issues before they arise. The future of Pharma is coming fast—let’s make sure we’re the ones driving it. Thanks for the inspiration from old and new friends: Heather Moses, Olivia Kager, Emma Vitalini, Dr. Goran Martinovic, Carlos Eid, MD, Maja Beilmann-Schramm, PhD, Steve Royle, Timothée Bompaire, Seyda Kanturer, Nina Fyhn, Hashim Tahir, Cisilie Bjerkset, Paul Simms, Lance Hill, Hadeel ElAmer, Bram Van Leeuwen Noreen Sajwani, Rina Newton, Audrey Krassnitzer, Florent Edouard #pharmageddon, #transformation